Efficacy and safety of liraglutide versus sitagliptin,both in combination with metformin,in Chinese patients with type 2 diabetes: a 26‐week,open‐label,randomized, active comparator clinical trial |
| |
| Authors: | L. Zang Y. Liu J. Geng Y. Luo F. Bian X. Lv J. Yang J. Liu Y. Peng Y. Li Y. Sun H. Bosch‐Traberg Y. Mu |
| |
| Affiliation: | 1. Department of Endocrinology, Chinese PLA General Hospital, Beijing, China;2. Department of Endocrinology, Second Hospital of Jilin University, Jilin, China;3. Department of Endocrinology, Harrison International Peace Hospital, Hengshui, China;4. Department of Endocrinology, Chongqing Three Gorges Central Hospital, Chongqing, China;5. Department of Endocrinology, Cangzhou People's Hospital, Cangzhou, China;6. Department of Endocrinology, PLA, Military General Hospital of Beijing, Beijing, China;7. Department of Endocrinology, Central Hospital of Minhang District, Shanghai, China;8. Department of Endocrinology, Fifth People's Hospital of Shanghai, Shanghai, China;9. Department of Endocrinology, Shanghai First People's Hospital, Shanghai, China;10. Department of Endocrinology, Third Hospital of Hebei Medical University, Shijiazhuang, China;11. Novo Nordisk (China) Pharmaceuticals Co., Ltd, Beijing, China;12. Novo Nordisk A/S, Copenhagen, Denmark |
| |
| Abstract: | |
| |
| Keywords: | Chinese liraglutide sitagliptin type 2 diabetes |
|
|
